Time to clarify confusion over market exclusivity for orphan medicines in the EU
This article was originally published in SRA
Executive Summary
Geneviève Michaux hopes that three recent court cases dealing with market exclusivity for orphan medicines might resolve some of the confusion surrounding this area of law.